Table 1.
Demographic and evaluated parameters of glioma patients
| Parameters |
Control
(n=30) |
Grade II
(n=23) |
Grade III
(n=19) |
Grade IV
(n=30) |
|---|---|---|---|---|
| Age (years) | 25 (21-50) | 26 (13-65) | 38 (20-75) | 51.5 (25-76) |
| YKL-40 (ng/ml) | 28.89 (1.119-66.55) | 46.08 (14.89-167.987) | 72.682(22.448-170.75) | 101.15 (21.20-198.77) |
| NLR | 1.62 (0.87-2.8) | 3.2 (1.23-11.5) | 4.33 (2.0-15) | 5.59 (3.1-18) |
| PC (10 11 /l) | 1.735 (0.86-2.74) | 1.87 (1.17-3.86) | 2.02 (1.13-3.63) | 2.45 (1.2-5.77) |
| OS (months) | - | 40 (16-159) | 17 (1-46) |
|
YKL-40: human chitinase-3-like-protein-1; NLR: neutrophil-lymophocyte ratio; PC: platelet count; OS: overall survival. All parameters are presented as median values.